Lifecore Biomedical, Inc. De (LFCR) Share-based Compensation (2010 - 2025)

Lifecore Biomedical has reported Share-based Compensation for 16 years, with the latest figure at $4.4 million in Q2 2025.

• On a quarterly basis, Share-based Compensation rose 173.28% year-over-year to $4.4 million in Q2 2025; TTM through May 2025 was $12.7 million, a 104.97% increase from a year earlier, with the FY2025 full-year figure at $10.2 million, up 63.81% from the prior year.
• Share-based Compensation was $4.4 million for Q2 2025 at Lifecore Biomedical, up from $2.6 million in the prior quarter.
• The five-year high for Share-based Compensation was $4.4 million in Q2 2025, with the low at $620000.0 in Q3 2021.
• Average Share-based Compensation over 5 years is $1.5 million, with a median of $859500.0 recorded in 2023.
• The sharpest annual moves came in 2023 and 2024: Share-based Compensation tumbled 38.27% in 2023, then soared 392.98% in 2024.
• Over 5 years, Share-based Compensation stood at $686000.0 in 2021, then soared by 61.52% to $1.1 million in 2022, then sank by 38.27% to $684000.0 in 2023, then jumped by 392.98% to $3.4 million in 2024, then increased by 29.51% to $4.4 million in 2025.
• The last three Share-based Compensation figures came in at $4.4 million (Q2 2025), $2.6 million (Q1 2025), and $3.4 million (Q4 2024), per Business Quant data.